State Street’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.9M Sell
1,487,156
-88,127
-6% -$1M ﹤0.01% 2282
2025
Q1
$10.5M Sell
1,575,283
-12,380
-0.8% -$82.3K ﹤0.01% 2502
2024
Q4
$17.5M Sell
1,587,663
-141,225
-8% -$1.56M ﹤0.01% 2296
2024
Q3
$21.2M Buy
1,728,888
+137,145
+9% +$1.69M ﹤0.01% 2172
2024
Q2
$21.5M Buy
1,591,743
+1,012,136
+175% +$13.7M ﹤0.01% 2131
2024
Q1
$7.82M Buy
579,607
+36,074
+7% +$487K ﹤0.01% 2718
2023
Q4
$2.86M Sell
543,533
-42,475
-7% -$223K ﹤0.01% 3184
2023
Q3
$2.31M Buy
586,008
+34,326
+6% +$135K ﹤0.01% 3267
2023
Q2
$5.86M Buy
551,682
+130,054
+31% +$1.38M ﹤0.01% 2922
2023
Q1
$3.51M Buy
421,628
+7,879
+2% +$65.6K ﹤0.01% 3120
2022
Q4
$3.82M Buy
413,749
+2,259
+0.5% +$20.9K ﹤0.01% 3159
2022
Q3
$5.28M Buy
411,490
+29,384
+8% +$377K ﹤0.01% 3033
2022
Q2
$5.05M Sell
382,106
-571,919
-60% -$7.56M ﹤0.01% 3098
2022
Q1
$20.1M Buy
954,025
+157,173
+20% +$3.31M ﹤0.01% 2398
2021
Q4
$19.1M Sell
796,852
-117,819
-13% -$2.83M ﹤0.01% 2503
2021
Q3
$23.3M Buy
914,671
+9,835
+1% +$250K ﹤0.01% 2374
2021
Q2
$30.5M Buy
904,836
+157,548
+21% +$5.3M ﹤0.01% 2214
2021
Q1
$29M Buy
747,288
+313,180
+72% +$12.2M ﹤0.01% 2120
2020
Q4
$26.9M Buy
434,108
+204,696
+89% +$12.7M ﹤0.01% 2049
2020
Q3
$7.68M Sell
229,412
-37,727
-14% -$1.26M ﹤0.01% 2581
2020
Q2
$6.37M Sell
267,139
-27,142
-9% -$647K ﹤0.01% 2642
2020
Q1
$6.74M Buy
294,281
+124,537
+73% +$2.85M ﹤0.01% 2483
2019
Q4
$4.81M Buy
169,744
+30,765
+22% +$871K ﹤0.01% 2868
2019
Q3
$2.99M Buy
+138,979
New +$2.99M ﹤0.01% 3061